市場概況

The Whole Exome Sequencing Market is poised for substantial growth, with a projected increase from USD 1.43 億で 2022 米ドルへ 3.75 10億まで 2029. This growth is expected to be driven by a compound annual growth rate (CAGR) の 14.2% の予測期間中に 2023-2029. Exome sequencing is a technique that selectively targets the subset of DNA responsible for encoding proteins, offering a cost-effective screening method for diagnosing genetic disorders. It has gained prominence in the field of drug discovery and development as an alternative to whole-genome sequencing, providing valuable insights into the genetic basis of diseases.

The market growth is driven by expanding applications in clinical diagnosis, particularly in the identification of rare diseases, where whole exome sequencing has proven to be a valuable tool. さらに, ongoing research and development in genomics and next-generation sequencing technologies contribute to the market expansion. The demand for personalized medicine, which relies on precise genetic profiling, also fuels the adoption of whole exome sequencing.

市場セグメンテーション

市場は製品に基づいて分割されています, 応用, エンドユーザー, そして地理.

製品ごとのセグメンテーション
System
Kits
サービス

Segmentation by Application
Second-Generation Sequencing – Sequencing, by Synthesis (SBS), Sequencing, by Hybridization and Ligation (SBL)
Third-Generation Sequencing

エンドユーザーごとのセグメンテーション
Diagnostics
Drug Discovery and Development
Personalized Medicine
その他

地理によるセグメンテーション
北米 – アメリカ, カナダ, メキシコ
ヨーロッパ – イギリス, ドイツ, フランス, イタリア, スペイン, およびその他のヨーロッパ
アジア太平洋地域 – 中国, 日本, インド, オーストラリア, 韓国, およびその他のアジア太平洋地域
ラテンアメリカ – ブラジル, アルゼンチン, およびその他のラテンアメリカ諸国
中東とアフリカ – GCC, 南アフリカ, およびその他の中東およびアフリカ

Personalized medicine, also known as precision medicine, aims to provide customized therapies based on individual genetic makeup. This approach has gained popularity due to advancements in genetics and understanding of gene influence on health and drug response. Tailoring treatments to patients leads to safer and more effective methods for various conditions. The personalized medicine segment is driven by factors including increasing cancer prevalence, affordability of therapy, fewer side effects, high adoption in developed markets, and development of innovative drugs. Strategic activities like partnerships, 合併, 買収, and product launches by market players are expected to further drive growth.

The North American region dominates the whole exome sequencing market due to factors such as increasing prevalence of genetic and chronic disorders, aging population, demand for personalized medicine, and favorable government initiatives. The burden of infectious diseases, including HIV, further fuels the demand for diagnosis and contributes to market growth. Mergers, 買収, launches, and partnerships among key players also drive growth in North America. With the growing prevalence of infectious diseases and introduction of new products, the North American market is expected to experience significant growth in the forecast period.

競争環境

The whole exome sequencing market is moderately consolidated, with a limited number of global and regional companies. Key players in the market include Bio-Rad Laboratories Inc., Eurofins Scientific SE, F. ホフマン・ラ・ロシュAG, Illumina Inc., and Thermo Fisher Scientific Inc. Other notable players include Azenta Inc., BGI Genomics Co. 株式会社, CD Genomics, Geneyx Genomex Ltd, Konica Minolta Inc. (Ambry Genetics Corporation), パーキンエルマー株式会社, Psomagen Inc (Macrogen Corp.), QIAGEN N.V., その他. These companies have significant market shares and established reputations.

最近の業界の発展

2月中 2023, Illumina Inc. delivered its first NovaSeqX Plus system to the Broad Institute, providing support for accessing Illumina’s sequencing service, including human whole genome and blended genome/exome products.

In May 2022, the Qatar Genome Program (QGP), a division of the Qatar Foundation (QF), partnered with Thermo Fisher Scientific to advance genomic research and enhance the clinical applications of predictive genomics in Qatar. This partnership aims to extend the benefits of precision medicine to Arab populations.

このレポートを購入する理由?

Get a detailed picture of the Global Whole Exome Sequencing Market
Identify segments/areas to invest in over the forecast period in the Global Whole Exome Sequencing Market
競争環境を理解する, 市場の主要企業
Excel 形式でのシナリオ全体の分析を容易にするための市場予測
3ヶ月間の戦略コンサルティングとリサーチサポート
シングルユーザーライセンスに提供される印刷認証